Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Common Equity (2016 - 2025)

Scientific Industries has reported Common Equity over the past 15 years, most recently at $10.7 million for Q4 2025.

  • For Q4 2025, Common Equity rose 16.93% year-over-year to $10.7 million; the TTM value through Dec 2025 reached $10.7 million, up 16.93%, while the annual FY2025 figure was $10.7 million, 16.93% up from the prior year.
  • Common Equity for Q4 2025 was $10.7 million at Scientific Industries, down from $12.5 million in the prior quarter.
  • Over five years, Common Equity peaked at $27.1 million in Q1 2022 and troughed at $7.8 million in Q1 2025.
  • A 5-year average of $14.8 million and a median of $12.5 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: surged 150.28% in 2022 and later plummeted 51.84% in 2023.
  • Year by year, Common Equity stood at $25.5 million in 2021, then crashed by 41.97% to $14.8 million in 2022, then decreased by 6.13% to $13.9 million in 2023, then plummeted by 34.32% to $9.1 million in 2024, then rose by 16.93% to $10.7 million in 2025.
  • Business Quant data shows Common Equity for SCND at $10.7 million in Q4 2025, $12.5 million in Q3 2025, and $7.9 million in Q2 2025.